Observers Give Mixed Reviews To Media's 'Dollymania'

In the seven weeks since the announcement of the successful cloning of a lamb called Dolly from an adult ewe, the scientific community has had time to reflect on what they've read, heard, or watched in the mass media. Among the scientists and bioethicists interviewed by The Scientist, there is unanimous excitement about the research itself. Despite this enthusiasm, observers and participants have a mixed reaction to the initial media coverage of the Dolly story. Some are pleased with news repor

| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

In the seven weeks since the announcement of the successful cloning of a lamb called Dolly from an adult ewe, the scientific community has had time to reflect on what they've read, heard, or watched in the mass media. Among the scientists and bioethicists interviewed by The Scientist, there is unanimous excitement about the research itself. Despite this enthusiasm, observers and participants have a mixed reaction to the initial media coverage of the Dolly story. Some are pleased with news reports, while others say journalists missed certain important scientific points and resorted to sensationalism.

Photo: AP/World Wide Photos A BREED APART: Dolly, the infamous cloned Finn Dorset lamb, sparked a maelstrom of drama and media hype. "Excessive" is the one word that Keith Campbell, a senior research scientist at the Roslin Institute near Edinburgh, Scotland, where the cloning experiments took place, uses to describe media events surrounding the announcement. Campbell ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Karen Young Kreeger

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo